Dermata Therapeutics, Inc. Warrant (DRMAW) Net Income by Year
Dermata Therapeutics, Inc. Warrant reported a net loss of $7.6M in fiscal year 2025. This represents an increase of 38.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Dermata Therapeutics, Inc. Warrant has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
DRMAW Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DRMAW Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Dermata Therapeutics, Inc. Warrant financials
Frequently Asked Questions
What was Dermata Therapeutics, Inc. Warrant's net income in fiscal year 2025?
Dermata Therapeutics, Inc. Warrant reported a net loss of $7.6M in fiscal year 2025.
How fast is Dermata Therapeutics, Inc. Warrant's net income growing?
Dermata Therapeutics, Inc. Warrant (DRMAW) net income rose by 38.5% year over year, from -$12.3M to -$7.6M in fiscal year 2025.
What was Dermata Therapeutics, Inc. Warrant's net income in the most recent quarter?
Dermata Therapeutics, Inc. Warrant (DRMAW) reported -$3.0M in net income in Q2 2026. This represents a decrease of 74.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Dermata Therapeutics, Inc. Warrant (DRMAW) reported on that line in every period on record.